Trial Profile
A phase II trial of Raviten for the treatment of intradialytic hypotension
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 31 May 2018
Price :
$35
*
At a glance
- Drugs MTR 104 (Primary)
- Indications Intradialytic hypotension
- Focus Therapeutic Use
- 31 May 2018 New trial record
- 29 May 2018 According to TrioxBio Inc. media release, the company plans to initiate phase II clinical trials for Raviten in the United States later in 2018.